NYSE · Retail-Drug Stores and Proprietary Stores
CVS Health Corporation (CVS)
CVS Health's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.
Last close
$87.85
−1.43% 1 day+17.7% 52 weeks
As of Sep 28, 2026, end of day (IEX). Not a live quote.
CVS · one year of daily closes
Sep 25, 2025 to Sep 28, 2026 · end of day · IEX
Closing prices, split-adjusted, from trades on the IEX exchange (published the next trading day). Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Key facts
- 1-day change
- −1.43%
- From $89.12 the session before
- 52-week change
- +17.7%
- Close vs close ~252 sessions earlier
- 52-week range
- $70.08–$110.58
- Lowest and highest closing prices
- Market cap
- $112.4B
- Last close × shares outstanding (SEC)
- Revenue (TTM)
- $415.1B
- 12 months to Jun 30, 2026
- Net income (TTM)
- $4.9B
- 12 months to Jun 30, 2026
- Diluted EPS (TTM)
- $3.79
- 12 months to Jun 30, 2026
Financials: trailing twelve months from CVS Health’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Jun 30, 2026.
Recent SEC filings
- Aug 17, 20268-KCurrent report: Executive or director change; Regulation FD disclosure
- Aug 5, 202610-QQuarterly report for the period ended Jun 30, 2026
- Aug 5, 20268-KCurrent report: Earnings results
- May 18, 20268-KCurrent report: Executive or director change; Shareholder vote results
- May 6, 202610-QQuarterly report for the period ended Mar 31, 2026
- May 6, 20268-KCurrent report: Earnings results
- Apr 3, 2026DEF 14AProxy statement for a shareholder meeting
- Mar 19, 20268-KCurrent report: Executive or director change
Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All CVS filings on EDGAR
Next earnings
~Oct 28, 2026Estimated
Past results were usually filed before the open
Estimated from past filing dates. CVS Health hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.
Insider activity (last 90 days)
- Open-market buys
- 0
- filings · 0 shares
- Open-market sales
- 0
- filings · 0 shares
No Form 4 filings with open-market purchases or sales in the 90 days to Oct 1, 2026.
Source: SEC EDGAR Form 4, filed in the 90 days to Oct 1, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.
Insider share counts and prices are as reported on Form 4.
With a free Vero account
What Vero tracks about CVS Health
Each new CVS Health filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own CVS, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.
CVS Health (CVS): questions, answered from the data
When is CVS Health's next earnings date?
What was CVS's last closing price?
Have CVS Health insiders bought or sold shares recently?
What did CVS Health file with the SEC most recently?
Is this page a recommendation to buy or sell CVS?
Related by SEC industry code
Closes are end of day (IEX), as of each page’s date. Grouped by SEC industry code (SIC).
Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.
Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.
Data as of Oct 1, 2026.